Literature DB >> 31656797

Safety and efficacy of restarting antiplatelet therapy after intracerebral hemorrhage.

Mi-Yeon Eun1, Jin-Man Jung2.   

Abstract

Entities:  

Year:  2019        PMID： 31656797      PMCID： PMC6789309          DOI： 10.21037/atm.2019.08.96

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  21 in total

1.  Use of aspirin in Chinese after recovery from primary intracranial haemorrhage.

Authors:  Boon-Hor Chong; Koon-Ho Chan; Vincent Pong; Kui-Kai Lau; Yap-Hang Chan; Ming-Liang Zuo; Wai-Man Lui; Gilberto Ka-Kit Leung; Chu-Pak Lau; Hung-Fat Tse; Jenny Kan-Suen Pu; Chung-Wah Siu
Journal:  Thromb Haemost       Date:  2011-12-21       Impact factor: 5.249

2.  Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study.

Authors:  Martin J O'Donnell; Denis Xavier; Lisheng Liu; Hongye Zhang; Siu Lim Chin; Purnima Rao-Melacini; Sumathy Rangarajan; Shofiqul Islam; Prem Pais; Matthew J McQueen; Charles Mondo; Albertino Damasceno; Patricio Lopez-Jaramillo; Graeme J Hankey; Antonio L Dans; Khalid Yusoff; Thomas Truelsen; Hans-Christoph Diener; Ralph L Sacco; Danuta Ryglewicz; Anna Czlonkowska; Christian Weimar; Xingyu Wang; Salim Yusuf
Journal:  Lancet       Date:  2010-06-17       Impact factor: 79.321

3.  Ultra-early hematoma growth in antithrombotic pretreated patients with intracerebral hemorrhage.

Authors:  J Roquer; R M Vivanco-Hidalgo; J Capellades; A Ois; E Cuadrado-Godia; E Giralt-Steinhauer; C Soriano-Tárraga; M Mola-Caminal; M Serra-Martínez; C Avellaneda-Gómez; J Jiménez-Conde; A Rodríguez-Campello
Journal:  Eur J Neurol       Date:  2017-10-16       Impact factor: 6.089

4.  Long term (13 years) prognosis after primary intracerebral haemorrhage: a prospective population based study of long term mortality, prognostic factors and causes of death.

Authors:  Björn M Hansen; Ola G Nilsson; Harald Anderson; Bo Norrving; Hans Säveland; Arne Lindgren
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-05-28       Impact factor: 10.154

5.  Long-term prognosis after recovery from primary intracerebral hemorrhage.

Authors:  S E Vermeer; A Algra; C L Franke; P J Koudstaal; G J E Rinkel
Journal:  Neurology       Date:  2002-07-23       Impact factor: 9.910

Review 6.  Brain hemorrhage recurrence, small vessel disease type, and cerebral microbleeds: A meta-analysis.

Authors:  Andreas Charidimou; Toshio Imaizumi; Solene Moulin; Alexandro Biffi; Neshika Samarasekera; Yusuke Yakushiji; Andre Peeters; Yves Vandermeeren; Patrice Laloux; Jean-Claude Baron; Mar Hernandez-Guillamon; Joan Montaner; Barbara Casolla; Simone M Gregoire; Dong-Wha Kang; Jong S Kim; H Naka; Eric E Smith; Anand Viswanathan; Hans R Jäger; Rustam Al-Shahi Salman; Steven M Greenberg; Charlotte Cordonnier; David J Werring
Journal:  Neurology       Date:  2017-07-26       Impact factor: 9.910

7.  Reasons for non-recruitment of eligible patients to a randomised controlled trial of secondary prevention after intracerebral haemorrhage: observational study.

Authors:  Amy E Maxwell; Mary Joan MacLeod; Anu Joyson; Sharon Johnson; Hawraman Ramadan; Ruth Bellfield; Anthony Byrne; Caroline McGhee; Anthony Rudd; Fiona Price; Evangelos Vasileiadis; Melinda Holden; Jonathan Hewitt; Michael Carpenter; Ann Needle; Stacey Valentine; Farzana Patel; Frances Harrington; Paul Mudd; Hedley Emsley; Bindu Gregary; Ingrid Kane; Keith Muir; Divya Tiwari; Peter Owusu-Agyei; Natalie Temple; Lakshmanan Sekaran; Suzanne Ragab; Timothy England; Amanda Hedstrom; Phil Jones; Sarah Jones; Mandy Doherty; Mark O McCarron; David L Cohen; Sharon Tysoe; Rustam Al-Shahi Salman
Journal:  Trials       Date:  2017-04-05       Impact factor: 2.279

8.  Cerebral Small Vessel Disease: A Review Focusing on Pathophysiology, Biomarkers, and Machine Learning Strategies.

Authors:  Elisa Cuadrado-Godia; Pratistha Dwivedi; Sanjiv Sharma; Angel Ois Santiago; Jaume Roquer Gonzalez; Mercedes Balcells; John Laird; Monika Turk; Harman S Suri; Andrew Nicolaides; Luca Saba; Narendra N Khanna; Jasjit S Suri
Journal:  J Stroke       Date:  2018-09-30       Impact factor: 6.967

9.  Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial.

Authors: 
Journal:  Lancet       Date:  2019-05-22       Impact factor: 79.321

10.  Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial.

Authors:  Rustam Al-Shahi Salman; David P Minks; Dipayan Mitra; Mark A Rodrigues; Priya Bhatnagar; Johann C du Plessis; Yogish Joshi; Martin S Dennis; Gordon D Murray; David E Newby; Peter A G Sandercock; Nikola Sprigg; Jacqueline Stephen; Cathie L M Sudlow; David J Werring; William N Whiteley; Joanna M Wardlaw; Philip M White
Journal:  Lancet Neurol       Date:  2019-05-22       Impact factor: 59.935
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.